BAY3427080 + Placebo (for BAY3427080)
Phase 1/2Completed 0 watching 0 views this week💤 Quiet
38
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post-menopausal Vasomotor Symptoms
Conditions
Post-menopausal Vasomotor Symptoms
Trial Timeline
Aug 1, 2016 → Mar 28, 2017
NCT ID
NCT02865538About BAY3427080 + Placebo (for BAY3427080)
BAY3427080 + Placebo (for BAY3427080) is a phase 1/2 stage product being developed by Bayer for Post-menopausal Vasomotor Symptoms. The current trial status is completed. This product is registered under clinical trial identifier NCT02865538. Target conditions include Post-menopausal Vasomotor Symptoms.
Hype Score Breakdown
Clinical
13
Activity
8
Company
7
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02865538 | Phase 1/2 | Completed |
Competing Products
19 competing products in Post-menopausal Vasomotor Symptoms